Chest Radiograph: Routine chest X‑rays are not always necessary; they are reserved for cases where pneumonia or pneumothorax is suspected. In A.G.’s case, his presentation is classic for an asthma attack without focal findings, so radiography is deferred.

Laboratory Tests: A complete blood count (CBC) reveals mild leukocytosis (WBC 11 × 10⁹/L) with a slight eosinophilia. Serum potassium is normal. Beta‑agonists may cause hypokalemia, so serial potassium levels will be monitored[13].

Nursing Diagnoses

Based on the data collected, the following nursing diagnoses are identified:

1. Ineffective breathing pattern related to bronchospasm and airway obstruction as evidenced by tachypnea, use of accessory muscles and dyspnea[1].
2. Ineffective airway clearance related to mucosal edema and increased mucus production, as evidenced by wheezing and reduced air entry[1].
3. Anxiety related to breathlessness and fear of suffocation, as manifested by restlessness and statements of fear[14].
4. Deficient knowledge regarding asthma triggers, medication adherence and self‑management, evidenced by inconsistent use of controller medication and exposure to triggers[2].
5. Risk for caregiver role strain related to inadequate follow‑up and difficulty managing chronic disease, as manifested by the mother’s report of missing appointments.

Evidence‑Based Management of Acute Exacerbation

Effective management of a pediatric asthma exacerbation involves prompt assessment, rapid initiation of therapy and frequent reassessment. A.G.’s treatment plan follows recommendations from the Canadian Pediatric Society and the National Asthma Education and Prevention Program (NAEPP). The management includes airway maintenance, oxygen therapy, bronchodilation, systemic steroids, and escalation of care when necessary.

Airway and Oxygen Therapy

Ensuring a patent airway and adequate oxygenation is the first priority. Supplemental oxygen should be administered when oxygen saturation falls below 92 %[12]. A.G. receives humidified oxygen via nasal cannula at 2 L/min, which increases his oxygen saturation to 95 %. Continuous oximetry is maintained.

Bronchodilators

Short‑Acting Beta₂‑Agonists (SABA): Salbutamol (albuterol) is the bronchodilator of choice for acute exacerbations[15]. An MDI with a spacer delivers the drug efficiently and reduces side effects[16]. A.G. receives 5 mg of nebulized salbutamol mixed with 0.5 mg ipratropium bromide via face mask. Nebulized therapy is used initially because of his moderate distress and difficulty with MDI technique. The combination of a beta₂‑agonist with an inhaled anticholinergic (ipratropium) improves lung function and reduces hospital admissions in moderate‑to‑severe crises[17]. The dose is repeated every 20 minutes for the first hour while monitoring heart rate and respiratory effort.

Ipratropium Bromide: Ipratropium bromide acts by blocking muscarinic receptors, reducing vagal‑mediated bronchoconstriction. It should be co‑administered with albuterol for three doses in moderate to severe exacerbations[18]. After the first three treatments, ipratropium is discontinued because evidence does not support continued use beyond initial therapy[19].

Corticosteroids

Systemic corticosteroids reduce airway inflammation, decrease mucus production and upregulate beta₂‑receptors. Children with moderate to severe exacerbations should receive steroids as early as feasible[20]. A.G. receives oral dexamethasone 0.6 mg/kg. Oral dosing has been shown to be as effective as intravenous methylprednisolone with fewer side effects[21]. Prednisone or prednisolone are alternatives; the dosing regimen is 1–2 mg/kg/day for 3–5 days. Evidence indicates no need to taper a short course of oral steroids for acute exacerbation.

Magnesium Sulphate

Children with incomplete response after one hour of SABA and steroids may benefit from intravenous magnesium sulphate. Meta‑analyses show that magnesium sulphate improves respiratory function and reduces hospital admissions in moderate to severe exacerbations[22]. Because A.G. responds to initial therapy with improved PEF (70 % of baseline) and oxygen saturation >94 %, magnesium is not administered.

Other Therapies

Continuous nebulization of albuterol may be considered if symptoms worsen despite intermittent doses[23]. Non‑invasive ventilation can alleviate muscle fatigue in severe cases[24]. Heliox (a helium–oxygen mixture) may improve gas exchange in refractory attacks[24]. Epinephrine is reserved for suspected anaphylaxis[25]. Intravenous beta‑agonists, aminophylline or ketamine are third‑line therapies and require intensive care monitoring.

Ongoing Assessment and Monitoring

Nurses continuously evaluate respiratory effort, mental status and vital signs. Peak flow is measured every 20 minutes to assess response. Signs of impending respiratory failure silent chest, fatigue, altered level of consciousness, rising PaCO₂ warrant immediate escalation and potential intubation. Cardiac monitoring is important because beta₂‑agonists may cause tachycardia and arrhythmias[13]. Serum potassium is monitored due to risk of hypokalemia.

Psychosocial Support

Acute asthma attacks can be frightening. A.G. expresses fear of dying; anxiety may exacerbate dyspnea. The nurse provides calming reassurance, stays with the patient during nebulization and coaches him to slow his breathing. The mother is included in the process to reduce her anxiety and reinforce understanding of treatment. Emotional support reduces sympathetic activation and may improve the child’s respiratory pattern.

Transition to Long‑Term Control: Education and Self‑Management

Once the acute episode is stabilized, attention shifts to prevention of future exacerbations. Under the stepwise approach advocated by the EPR‑3 guidelines, controller medications are escalated or de-escalated based on severity[26].

Stepwise Pharmacotherapy

• Step 1 (Intermittent asthma): Use of a short‑acting beta₂‑agonist as needed for symptom relief[27].
• Step 2 (Mild persistent): A low‑dose inhaled corticosteroid (ICS) is the preferred long‑term controller; montelukast is an alternative[28].
• Step 3 (Moderate persistent): For children 0–4 years, a medium‑dose ICS is recommended; for those aged 5–11 years, either a medium‑dose ICS or a combination of low‑dose ICS and a long‑acting beta₂‑agonist (LABA) or leukotriene receptor antagonist can be used[29]. In adolescents and adults, combination therapy with low‑dose ICS plus LABA is preferred.
• Step 4: Medium‑dose ICS plus LABA or montelukast in young children; medium‑dose ICS plus LABA in older children and adolescents[30].
• Step 5: High‑dose ICS plus LABA or montelukast for all age groups; consider biologic therapy (omalizumab) for allergic asthma[31].
• Step 6: High‑dose ICS plus LABA with oral systemic corticosteroids; referral to an asthma specialist and evaluation for biologics[32].

Stepping up therapy is indicated when asthma remains uncontrolled despite adherence, proper inhaler technique and removal of modifiable triggers. Stepping down is considered after maintaining good control for three to six months. The case study provides an opportunity to practice adjusting therapy based on guidelines and patient response.

Inhaler Technique and Adherence

Many children misuse their inhalers, reducing medication deposition in the lungs. Nurses must teach the correct technique using an age‑appropriate device and a spacer. A.G. and his mother practice using the MDI with a spacer; they are instructed to shake the inhaler, exhale fully, place the mouthpiece in his mouth, press the canister and inhale slowly and deeply, then hold the breath for 10 seconds before exhaling. The nurse emphasises the importance of daily controller medication even when asymptomatic, using a sticker chart to encourage adherence. The mother is educated about obtaining refills and not stopping the inhaler prematurely.

Asthma Action Plan

An individualized asthma action plan is developed in collaboration with the family. These plans divide management into zones: Green (well controlled), Yellow (worsening symptoms) and Red (severe exacerbation). Each zone lists symptoms, peak flow ranges, medication instructions and when to seek medical help. EPR‑3 guidelines recommend that all patients have an action plan[33]. A.G.’s plan includes daily budesonide 200 mcg twice daily (Step 2), SABA use as needed for relief, and instructions to increase controller dosage or seek medical attention for persistent symptoms. The plan is shared with the school nurse and kept at home.

Environmental Control and Trigger Avoidance

Identifying and controlling triggers are essential for long‑term management. The nurse reviews potential triggers with A.G. and his mother:

• Allergens: Dust mites (encourage mattress and pillow covers, weekly hot‑water washing of bedding), pet dander (consider limiting exposure), molds (repair leaks and clean moldy surfaces), cockroaches (pest control).
• Air pollutants: Avoid second‑hand tobacco smoke; do not allow smoking in the home.
• Viral infections: Encourage hand hygiene and influenza vaccination; continue to monitor after colds.
• Exercise: Use a SABA 15 minutes before vigorous activity; ensure warm‑up and cool‑down.
• Weather changes: In cold weather, use a scarf over the nose and mouth; maintain indoor humidity.

Diet and Weight Management

Obesity exacerbates asthma symptoms and reduces medication responsiveness. The nurse assesses A.G.’s body mass index (BMI) and provides guidance on balanced nutrition, physical activity, and limiting sugary drinks. Consuming a diet rich in fruits, vegetables and omega‑3 fatty acids may reduce airway inflammation. The family is connected with a nutritionist for further support.

Psychosocial and Cultural Considerations

Asthma management in children must consider family beliefs, cultural practices and health literacy. The nurse uses plain language, demonstration and the teach‑back method to ensure comprehension. Given the mother’s employment schedule, the nurse discusses setting reminders and integrating medication administration into daily routines. They address concerns about steroid side effects and emphasize the benefits of adherence. Because the family has limited resources, the social worker assists with insurance coverage for medications and home modifications.

Follow‑Up and Continuity of Care

Fragmentation of care is a recognized barrier in pediatric asthma management[2]. To ensure continuity, the nurse schedules a follow‑up appointment with the primary care provider within two weeks. The plan includes routine visits every three months, or sooner if control deteriorates. The case study underscores the need for multidisciplinary collaboration: the pediatrician, nurse, respiratory therapist, school nurse and social worker all contribute to long‑term control. Shared decision‑making is encouraged to enhance adherence and empower A.G. and his family[2].

Discussion

This pediatric asthma case study illustrates the complexities of managing acute exacerbations while planning for long‑term control. A.G.’s presentation highlights common challenges: poor adherence to controller medication, inadequate follow‑up and exposure to environmental triggers. The acute management followed evidence‑based guidelines: rapid assessment; oxygen supplementation when saturation dropped below 92 %; administration of inhaled beta₂‑agonists and ipratropium; and timely initiation of systemic corticosteroids[34]. A.G. improved after three nebulized treatments and a single dose of dexamethasone, avoiding intravenous magnesium sulphate. Continuous monitoring ensured early recognition of complications. Psychosocial support alleviated anxiety, an often under‑recognized component of asthma care.

The transition to long‑term management emphasized the stepwise pharmacologic approach. Inhaled corticosteroids remain the foundation of controller therapy at all steps beyond intermittent asthma[35]. Combining an inhaled corticosteroid with a LABA or leukotriene receptor antagonist is recommended for children with moderate to severe persistent asthma[29]. Biologic therapies such as omalizumab are now available for allergic asthma unresponsive to conventional therapy[31]. However, medication alone cannot achieve control. Education on inhaler technique, adherence, trigger avoidance and self‑monitoring is critical. The case underscores how knowledge deficits and socio‑economic barriers lead to poor adherence; targeted education and social support can mitigate these issues.

The case study also reflects systemic challenges. Qualitative research has shown that pediatric asthma care is often fragmented, with GPs prioritizing acute symptom management and underestimating chronic care[2]. A lack of structured follow‑up contributes to insufficient self‑management skills[2]. Nurses play a pivotal role in bridging these gaps by coordinating follow‑up, facilitating communication among healthcare providers and advocating for integrated care. Shared decision‑making enhances adherence and empowers families to take ownership of asthma control[2]. Addressing social determinants housing quality, air pollution, poverty requires broader public health interventions.

Finally, the case highlights the psychological impact of asthma. Anxiety and fear can exacerbate symptoms and hinder adherence. Nurses must adopt a family‑centered approach, acknowledging emotional and cultural factors. Community resources, support groups and school nurse involvement can provide additional support.

Conclusion

A thorough pediatric asthma case study offers invaluable lessons for nursing practice. It reinforces the need for prompt, evidence‑based management of acute exacerbations, guided by reputable sources such as the Canadian Pediatric Society and StatPearls[34][26]. The stepwise approach to long‑term control underscores the central role of inhaled corticosteroids and emphasises tailored therapy based on severity and patient response[26]. Nurses must assess severity, administer appropriate medications, monitor response and anticipate complications. Equally important is education on inhaler technique, adherence and avoidance of triggers. Effective communication and shared decision‑making empower children and caregivers to manage asthma proactively.

Case‑based learning also exposes the systemic challenges inherent in pediatric asthma care, such as fragmentation of services and disparities linked to socio‑economic status. By coordinating follow‑up, facilitating multidisciplinary collaboration and addressing social determinants, nurses can help mitigate these barriers. Ultimately, an integrative approach combining pharmacologic therapy, education, psychosocial support and public health initiatives is vital for improving outcomes and quality of life for children with asthma.

Bibliography

StatPearls Publishing. Pediatric Asthma (Nursing). Treasure Island, FL: StatPearls Publishing, 2024. Accessed April 12, 2026. https://www.ncbi.nlm.nih.gov/books/NBK568735/.

Søndergaard, Jens, et al. “Improving Asthma Care in Children: Revealing Needs and Bottlenecks through In-Depth Interviews.” BMC Primary Care (2024). Accessed April 12, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC11655526/.

Canadian Paediatric Society. “Managing an Acute Asthma Exacerbation in Children.” Canadian Paediatric Society. Accessed April 12, 2026. https://cps.ca/en/documents/position/managing-an-acute-asthma-exacerbation.

[1] [3] [4] [5] [6] [7] [8] [9] [10] [14] [18] [21] [24] [26] [27] [28] [29] [30] [31] [32] [33] [35] Pediatric Asthma (Nursing) – StatPearls – NCBI Bookshelf

https://www.ncbi.nlm.nih.gov/books/NBK568735/

[2]  Improving asthma care in children: revealing needs and bottlenecks through in-depth interviews – PMC 

https://pmc.ncbi.nlm.nih.gov/articles/PMC11655526/

[11] [12] [13] [15] [16] [17] [19] [20] [22] [23] [25] [34] Managing an acute asthma exacerbation in children | Canadian Paediatric Society

https://cps.ca/en/documents/position/managing-an-acute-asthma-exacerbation